Main Article Content
Background Childhood obesity is a widespread and growing problem associated with health problems such as metabolic syndrome, diabetes mellitus and cardiovascular disease. A lowgrade chronic inflammatory state, reflected by decreased adiponectin and increased highly sensitive Creactive protein (hsCRP) levels, may play a role in metabolic syndrome associated with obesity.
Objective To assess and compare adiponectin and hsCRP levels in obese and nonnal weight children.
Methods We conducted a cross-sectional, casecontrolled study in Manado from May to July 2010. Subjects were selected from obese, but otherwise healthy children aged 9-15 years. Control subjects were schoolmates 'With normal body mass index (BMI). We perfonned physical examinations, measured blood pressure, weight and height, and calculated BMI for all subjects. After an overnight fast, all subjects were tested for fasting blood glucose, adiponectin and hsCRP levels.
Results The mean adiponectin level in the obese group was 3.6 μg/mL (SD 1.43), lower than that of the normoweight group, 4.8 μg/mL (SD 1.67) (P<0.0001). The mean hsCRP level in the obese group was 3.3 mg/L (SD 3.62) while that of the normoweight group was 0.8 mg/L (SD 1.39) (P<0.0001). There was no inverse correlation between adiponectin and hsCRP levels in obese group (r= 0.048; P= 0.362).
Conclusions Lower adiponectin and higher hsCRP levels in the obese group is consistent 'With a low-grade chronic inflammatory state. Other factors that influence adiponecrin and hsCRP production or inflammatory pathways of other adipokines need further evaluation. Early intervention is needed to reduce body weight in obese children.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
2. Redinger RN. T he pathophysiology of obesity and its clinical manifestations. Gastroenterol Hepatol. 2007;3:856-63.
3. Trujillo ME, Scherer PE. Adipose tissuederived factors: impact on health and disease. Endocr Rev. 2006;27:762- 78.
4. Stern N, Osher E, Greenman Y. Hypoadiponectinemia as a marker of adipocyte dysfunction part I: the biology of adiponectin. J Cardiometab Syndr. 2007;2:174-82.
5. Valle M, Martos R, Gasc6n F, Cafiete R, Zafra MA, Morales R. Lowgrade systemic inflammation, hypoadinopectinemia and a high concentration of leptin are present in very young obese children, and correlate Mth metabolic syndrome. Diabetes Metab. 2005;31:55-62.
6. Weiss R, Dziura J, Burgert TS, Tamborlane Wv, Taksali SE, Yeckel Cw, et al. Obesity and the Metabolic Syndrome in Children and Adolescents. N Engl j Med. 2004;350,2362-74.
7. Abraham j, Campbell CY, Cheema A, Gluckman Tj, Blumenthal RS. C-reactive protein in cardiovascular risk assessment: a review of the evidence. J Cardiometab Syndr. 2007;2;119-23.
8. Wu DM, Chu NF, Shen MH, Wang SC. Obesity, plasma high sensitivity C-reactive protein levels and insulin resistance status among school children in Taiwan. Clin Biochem. 2006;39;810-5.
9. Kapiotis S, Holzer G, Schaller G, Haumer M, Widhalm H, Weghuber D, et al. A proinflammatory state is detectable in obese children and is accompanied by functional and morphological vascular change. Arterioscler T hromb Vasc Bio!. 2006;26;2541-6.
10. Winer JC, Zern TL, Taksali SE, Dziura J, Cali AMG, Wollschlager M, et al. Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome. J Clin Endocrinol Metab. 2006;91:4415-23.
11. Mexitalia M. Nutrisi pencegahan: prudent diet. In: Gunawan G, editor. Tumbuh kembang, nutrisi dan endokrin. 5th Continuing Professional Development; Banjannasin 2006 Februari 1819. Banjarmasin: Indonesian Pediatric Society South Borneo Branch; 2006: p. 29A2.
12. Nagel G, Rapp K, Wabitsch M, Bilchele G, Kroke A, Zollner I, et al. Prevalence and cluster of cardiometabolic biomarkers in overweight and obese schoolchildren: results from a large survey in southwest Germany. Clin Chem. 2008;54:317-25.
13. Ohashi K, Ouchi N, Kihara S. Adiponectin I164T mutation is associated 'With the metabolic syndrome and coronary artery disease. J Am Coli Cardio!. 2004;43; 1195-1200.
14. Stumvoll M, Tschritter 0, Fritsche A. Association of the TG polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction 'With family history of type 2 diabetes. Diabetes. 2002;51;37-41.
15. Schiel R, Beltschikow W, Kramer G, Stein G. Overweight, obesity and elevated blood pressure in children and adolescents. EurJ Med Res. 2006;11:97-101.
16. Hendarto A. Telaah peran leptin, adiponektin, tumor necrosis factora., C reactive protein, asupan karoohidrat dan lemak terhadap resistensi insulin pada anak lelaki superobes usia 59 tahun [dissertation]. Jakarta: University of Indonesia, 2009.
17. Punthakee Z, Delvin EE, O'Loughlin J, Paradis G, Levy E, Platt RW, et al. Adiponectin, adiposity, and insulin resistance in children and adolescents. J Clin Endocrinol Metab. 2006;91;2119-25.
18. Araki S, Dobashi K, Kubo K, Asayama K, Shirahata A. High molecular weight, rather than total, adiponectin levels better reflect metabolic abnonnalities associated with childhood obesity. J Clin Endocrinol Metab. 2006;91:5113-6.